Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.

Efpia Transparency code - MALTA

Publication of data regarding the interaction between the pharmaceutical industry and healthcare professionals

Starting from 30th June 2016, the data related to the professional collaboration between A M Mangion Ltd and Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs), and to Research and Development for the year 2015 will be available on our website.

Absolute transparency through the publication of these data is the objective and clear choice of the pharmaceutical companies having adopted the Disclosure Code of PRIMA in implementation of the Code of EFPIA (European Federation of Pharmaceutical Industries and Associations).

The professional collaboration between pharmaceutical companies and healthcare professionals, already well regulated for some time, takes place in various fields of activities:

  1. Research and development of new drugs through clinical trials conducted in hospitals, universities and in public or private Healthcare Organizations;
  2. Scientific consulting;
  3. Scientific seminar and conferences which provide information and updates;
  4. Conferences and Continuing Medical Education courses organized by public structures, universities and scientific communities and accredited CME providers

The exchange of knowledge between the pharmaceutical industry and healthcare professionals, with their expertise and practical experience, allows for the contribution of valuable information to the advancement of research and development thus making more efficient and effective drugs available for the health of all patients.
These interactions, besides being regulated by national and international norms, are based on the mutual respect of roles in a transparent context of the ethical regulations and principles of PRIMA which establishes strict control measures conducted by third parties following specific institutional procedures presided by magistrates appointed by the Chief Justice.
You can access the data, published in accordance with the laws of data protection, relative to the HCPs who have granted consent of data publishing and in aggregate form for those who have not.

  1. Therapy & Wellness

    Therapy and

    Discover all the therapeutic areas where Menarini is present with products marketed in Italy.

    Enter »

  2. Diagnostics


    A. Menarini Diagnostics responds in a concrete, comprehensive and competent manner to diagnostic and preventive medicine investigations.

    Enter »

  3. Biotechnology


    Menarini Biotech represents Italian excellence in research in the field of biologic drugs. Cutting-edge technologies

    Enter »

Quality first


Quality: point of departure and arrival for our drugs.